RTN1 and diffuse large B-cell lymphoma: It is recommended that the prognostic efficacy of RTN1 is evaluated in more annotated cohorts with DLBCL using subtle techniques such as PCR, quantitative real-time PCR, immunohistochemistry (IHC) to validate the current findings.